Arrhythmia-induced cardiomyopathy (AIC) is a potentially reversible condition in which left ventricular dysfunction is induced or mediated by atrial or ventricular arrhythmias. Cellular and extracellular changes in response to the culprit arrhythmia have been identified, but specific pathophysiological mechanisms remain unclear. Early recognition of AIC and prompt treatment of the culprit arrhythmia using pharmacological or ablative techniques result in symptom resolution and recovery of ventricular function. Although cardiomyopathy in response to an arrhythmia may take months to years to develop, recurrent arrhythmia can result in rapid decline in ventricular function with development of heart failure, suggesting residual ultrastructural abnormalities. Reports of sudden death in patients with normalized left ventricular ejection fraction cast doubt on the complete reversibility of this condition. Several aspects of AIC, including specific pathophysiological mechanisms, predisposing factors, optimal therapeutic strategies to prevent ultrastructural changes, and long-term risk of sudden death remain unresolved and need further research. (J Am Coll Cardiol 2015;66:1714-28) 
WHAT IS AIC?
AIC is a condition in which atrial or ventricular tachyarrhythmias or frequent ventricular ectopy result in left ventricular (LV) dysfunction, leading to systolic HF (1, 2) . The hallmark of this condition is partial or complete reversibility once arrhythmia control is achieved. AIC can be classified into 2 categories: one in which arrhythmia is the sole reason for ventricular dysfunction (arrhythmia induced) and another in which the arrhythmia exacerbates ventricular dysfunction and/or worsens HF in a patient with concomitant heart disease (arrhythmia mediated) (3).
EPIDEMIOLOGY
The incidence and prevalence of AIC are uncertain, but AIC appears underrecognized. Atrial fibrillation (AF) is present in 10% to 50% of patients with HF; many patients with cardiomyopathy and AF have worsening symptoms and ventricular function solely due to poorly controlled ventricular rates (4) . In 2 studies of adult patients with focal atrial tachycardia (AT), the incidence of AIC was 8.3% to 10% (5,6), whereas 28% had AIC in a pediatric multicenter study of atrial ectopic tachycardia (AET) (7) . The incidence of AIC was 9% to 34% in patients with frequent premature ventricular complexes (PVCs) and/or nonsustained ventricular tachycardia referred for electrophysiological evaluation (8) (9) (10) .
PATHOPHYSIOLOGY, MECHANISMS, AND PREDISPOSING FACTORS PATHOPHYSIOLOGY: INSIGHTS FROM ANIMAL
MODELS. Chronic rapid pacing has long been recognized to cause HF in animal models (11) . LV remodeling and HF occur in a time-dependent and highly predictable manner, similar to the phenotype of AIC (12) (13) (14) (15) (16) (17) (18) . Due to the rapidly progressive and predictable nature of pacing to induce cardiomyopathy, the natural history of LV remodeling and failure, neurohormonal activation and signaling, and cell viability and molecular pathways have been examined in detail. The Central Illustration shows the natural history and contributing cellular and molecular events in rapid pacing-induced cardiomyopathy and HF.
LV REMODELING AND HF. During the early phase (the first 3 to 7 days) of rapid pacing, LV dilation occurs, with a decline in LVEF (12) (13) (14) (15) . This early remodeling phase is not accompanied by compromises in cardiac output or systemic perfusion pressures. By the second week, LV dilation, a fall in LVEF, and elevations in central venous and pulmonary capillary wedge pressures and systemic vascular resistance ensue (12) (13) (14) (15) (16) (17) . Eventually HF develops.
Whereas initial manifestations are adaptive, sustained rapid pacing affects LV load-ejection relationships, specifically, the pre-load recruitable LV stroke-work relationship (17) , the LV systolic wall stress-ejection relationship, and the slope of the LV endsystolic pressure-volume relationship (18) .
LV dilation and dysfunction are accompanied by a decline in intrinsic myocardial contractile function.
NEUROHORMONAL ACTIVATION. Rapid pacing in animals results in a predictable, timedependent change in neurohormonal pathways and synthesis and release of bioactive peptides (19) (20) (21) (22) (23) (24) (25) . The levels of plasma atrial natriuretic peptide and B-type natriuretic peptide (BNP) increase early, concomitant with LV dilation (19, 21) ; eventually natriuretic peptide levels plateau or decrease, likely due to suppression of synthesis and increased degradation by endopeptidases. Another hallmark is activation of sympathetic pathways, resulting in norepinephrine spillover (20, 21) . Consistent with the phenotype of progressive LV failure, rapid pacing invariably causes activation of the renin-angiotensin-aldosterone system (20, 25) . Other bioactive molecules activated and released include endothelin and inflammatory cytokines such as tumor necrosis factor alpha (24) .
Whereas mediators of vasoconstriction are induced, mediators of vasodilation, such as the response to nitric oxide, become impaired (22, 23) . Several key aspects regarding these temporal changes in the neurohormonal/bioactive signaling pathways hold relevance. First, shifts in key neurohormonal pathways, such as the natriuretic peptides and the reninangiotensin-aldosterone system, likely reflect shifts in underlying LV functional status from a "compen- Gopinathannair et al.
Arrhythmia-Induced Cardiomyopathy with pacing-induced cardiomyopathy (26) , with accompanied prolongation of myocardial Ca 2þ transients and defects in Ca 2þ cycling (27) . These changes in the force-frequency relation and Ca 2þ handling are a manifestation of prolonged rapid pacing and are present when definable changes in LV systolic function have already occurred (27) (28) (29) (30) . The summation of changes in Ca 2þ handling results in fundamental defects in the excitation-contraction coupling process, leading to defects in absolute myocyte contractile function and inotropic responsiveness (27) (28) (29) (30) .
In isolated myocyte preparations, intrinsic defects in the rate and extent of shortening, as well as defects in the rate of relaxation, have been identified as cardiomyopathy develops and progresses (20, 28, 31) .
Changes in cellular growth and viability ensue (32, 33) .
Chronic rapid pacing induces several proapoptotic cascades (34 In response to rapid pacing in animals, left ventricular (LV) remodeling and heart failure occur in a time-dependent and highly predictable manner, similar to the phenotype of arrhythmia-induced cardiomyopathy. Several cellular and molecular events in response to the initial tachyarrhythmia stimulus take place over a period of approximately 3 to 4 weeks and involve both extracellular matrix (ECM) and myocyte remodeling. Specifically, there is loss of normal extracellular matrix and architecture. This, coupled with alterations in cellular growth and viability, defects in Ca 2þ handling, and neurohormonal activation, results in LV dilation and severe contractile dysfunction. The natural history of rapid pacing-induced cardiomyopathy progresses from a compensatory phase (approximately >7 days) to an LV dysfunction phase (approximately 1 to 3 weeks) to an LV failure phase (approximately >3 weeks), characterized by progressive LV dilation and dysfunction and increasing neurohormonal activation. ATPase ¼ adenosine triphosphatase; RAAS ¼ renin-angiotensin-aldosterone system.
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were placed in a temporal context, then LV myocyte remodeling (cell shape and architecture) is likely to occur early, followed by abnormalities in excitationcontraction and changes in cell viability.
EXTRACELLULAR REMODELING. Although remodeling occurs within the myocyte, robust changes also occur within the extracellular matrix (35, 36 (45) . In a longitudinal study of patients with high PVC burden, those who developed cardiomyopathy had wider PVC QRS width versus those who did not, suggesting baseline myocardial fiber disruption that portends an increased risk (46) .
CLINICAL FEATURES AND DIAGNOSIS
The key diagnostic feature of AIC is the presence of a pathological tachycardia or persistent arrhythmia (PVC) in the presence of an otherwise unexplained cardiomyopathy. The relationship of arrhythmia to cardiomyopathy can be difficult to determine because an arrhythmia could exist for years before its recognition and before cardiomyopathy develops.
Although a high index of clinical suspicion may point to subtle diagnostic clues, the condition may go unrecognized for years. The presentation can be late only after manifest systolic HF develops. Similarly, if
Arrhythmia-Induced Cardiomyopathy the arrhythmia is detected early but a nonaggressive approach is taken, progressive worsening of symptoms and insidious development of cardiomyopathy ensue. It can be difficult to determine whether an arrhythmia is the initiator or consequence of cardiomyopathy in a patient with tachycardia and HF.
Thus, AIC raises a "chicken or egg" question (47) .
Frequently, the arrhythmia is considered secondary and is not treated effectively when, in fact, arrhythmia control is necessary for full recovery. Management of AF consists of rate and/or rhythm control. In those with AF and cardiomyopathy, the ideal target heart rate remains uncertain. For those with permanent AF, lenient rate control (resting heart rate <110 beats/min) has been advocated over strict rate control (resting heart rate <80 beats/min and heart rate with moderate exercise <110 beats/min) (55) . However, in the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) trial (55), most patients were rate controlled before enrollment (baseline heart rate 96 beats/min) and were asymptomatic without cardiomyopathy. Follow-up was short, and development of AIC was not specifically considered.
Several methods are available for AF rate control (56) . Achieving adequate rate control may require drug combinations and frequent regimen changes (57) . However, these data may not directly apply to AF-mediated AIC because rate irregularity may contribute to symptoms and facilitate development of AIC (40) . Although AV nodal ablation with pacemaker implantation can provide effective rate control (58) and regularize the rate, this strategy changes ventricular activation, even if cardiac resynchronization therapy is used; therefore, it should only be considered if rhythm and/or rate control cannot be AV ¼ atrioventricular. 
AIC IN CHILDREN
In children, dilated cardiomyopathy is the most common reason for heart transplant (84) . Nearly 40% of children with cardiomyopathy undergo heart transplant or die within 2 years of presentation (85) .
AIC must be considered in this setting. In the largest pediatric series of AIC, AET (59%) and permanent junctional reciprocating tachycardia (PJRT; 23%) were the most common arrhythmias represented. Ventricular arrhythmias were uncommon (86) . 
PEDIATRIC ARRHYTHMIAS ASSOCIATED WITH AIC.

A t r i a l e c t o p i c t a c h y c a r d i a .
AET is the most common arrhythmia associated with AIC in children (96).
Although P-wave morphology and axis usually differ from sinus rhythm, AET foci near the sinus node are hard to differentiate from sinus tachycardia, especially in patients with HF, when tachycardia is expected. Increased automaticity is the most likely mechanism; others include triggered activity and micro-reentry (97-100). AET usually occurs without structural heart disease but has been described after congenital heart disease surgery (100) and in the setting of channelopathies (101).
In a multicenter study of 249 children with AET, 28% had AIC ( infancy, is associated with high morbidity and mortality (110) (111) (112) . In an early study, mortality was 34%, with sudden death occurring in infants (113) . In a multicenter study of nonoperative JET, overall mortality was low, with all deaths occurring in children #6 months of age (114) . Although only 16%
presented with HF, the tachycardia was incessant in >40%. JET can be incessant or paroxysmal, although infants <6 months of age are more likely to have incessant tachycardia.
Medical management is commonly undertaken (89%) as the first step but was variably effective, with a variety of drugs used. Beta-blockers were the most common first-line agent, but the majority required $2 drugs for control, with complete suppression seen in only 11%. Amiodarone alone or in combination was cited as the most effective for rate or rhythm control.
Catheter ablation for JET can be accomplished with the preservation of AV nodal conduction (115, 116) , and cryoablation has been associated with success rates similar to those of radiofrequency ablation but without AV block (114, 117) . V e n t r i c u l a r t a c h y c a r d i a a n d P V C s . Although rare in children, ventricular tachycardia can result in AIC. 
